Skip to main content
Clinical Trials/NCT04810013
NCT04810013
Completed
Not Applicable

Noninvasive Measurement of the Cerebral Autoregulation in Neonates and Infants With Complex Congenital Heart Disease After Cardiac Surgery With Cardiopulmonary Bypass at the Pediatric Intensive Care Unit (PICU)

University Hospital Tuebingen1 site in 1 country80 target enrollmentJune 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Complex Congenital Heart Disease
Sponsor
University Hospital Tuebingen
Enrollment
80
Locations
1
Primary Endpoint
Range of mean arterial blood pressure
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Feasibility of non-invasive cerebral autoregulation measurement at the PICU and impact of changes in oxygen supply

Detailed Description

Cerebral protection is a major issue in the treatment of neonates and infants with complex congenital heart disease, because most common long-term morbidities of newborn heart surgery are related not to the heart, but instead to the cognitive challenges experienced by this population. Disruption of cerebral autoregulation in the postoperative period may contribute to brain injury in these patients. Blood pressure management, respirator management and red blood cell transfusion management after cardiopulmonary bypass surgery using endpoints such cerebral autoregulation monitoring might provide a method to optimize organ perfusion and improve neurologic outcome from cardiac surgery in the vulnerable postoperative period. Primary Objectives: Feasibility of non-invasive cerebral autoregulation measurement at the PICU: Identification of the range of mean arterial blood pressure (MAP) with optimal vasoreactivity (MAPOPT), indicating intact cerebral autoregulation. Secondary Objectives: Impact of decreased oxygen delivery, increased cerebral oxygen extraction, decreased cardiac output, arterial hypotension, severe hypoxemia and/or severe anemia on cerebral autoregulation.

Registry
clinicaltrials.gov
Start Date
June 1, 2020
End Date
November 30, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • term (37-42 weeks gestation) newborns
  • pre- or postnatally diagnosed critical congenital heard disease (CHD)
  • admitted to the pediatric cardiac intensive care unit at the Children's Hospital of Tübingen

Exclusion Criteria

  • birth weight \<2 kg
  • history of neonatal depression (5-min APGAR\<5, cord blood pH\<7.0, sepsis, or birth asphyxia)
  • perinatal seizures
  • evidence of end-organ injury
  • preoperative cardiac arrest
  • significant preoperative intracerebral hemorrhage such as grade 3 or 4 intraventricular hemorrhage.

Outcomes

Primary Outcomes

Range of mean arterial blood pressure

Time Frame: 4within 8 hours after cardiac surgery at the PICU

Measurement of the range of mean arterial blood pressure (MAP) with optimal vasoreactivity (MAPOPT)

Secondary Outcomes

  • Influence of changed fractional cerebral oxygen extraction (cFTOE) on cerebral autoregulation(within 8 hours after cardiac surgery at the PICU)
  • Influence of changed arterial oxygen saturation on cerebral autoregulation(within 8 hours after cardiac surgery at the PICU)
  • Neurological outcome measure(at age of 2 years)
  • Detection of severe brain injury(before surgery, 12 hours, 48 hours, 72 hours post surgery and before discharge)
  • Influence of changed arterial blood pressure on cerebral autoregulation(within 8 hours after cardiac surgery at the PICU)
  • Influence of changed blood hemoglobin concentration on cerebral autoregulation(within 8 hours after cardiac surgery at the PICU)

Study Sites (1)

Loading locations...

Similar Trials